 Although flexible sigmoidoscopy FS as a screening tool has a much higher test sensitivity than fecal occult blood tests FOBT for colorectal cancer and high-risk adenomas, randomised trials with long-term follow-up are missing. The primary aim is to evaluate the effect on CRC mortality and morbidity by screen detection of CRC and removal of precursor lesions polypectomy of adenomatous polyps 